These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1918221)

  • 1. Ceftriaxone in treatment of serious infections. Pneumonia and lower respiratory tract infections.
    Brown R
    Hosp Pract (Off Ed); 1991 Sep; 26 Suppl 5():37-42; discussion 59-62. PubMed ID: 1918221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Once-daily ceftriaxone in the treatment of lower respiratory tract infections.
    Brown R
    Chemotherapy; 1991; 37 Suppl 3():11-4. PubMed ID: 1884650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Once-daily intramuscular ceftriaxone in the outpatient treatment of severe community-acquired pneumonia in children.
    Leibovitz E; Tabachnik E; Fliedel O; Steinberg S; Miskin A; Askenazi A; Barak Y
    Clin Pediatr (Phila); 1990 Nov; 29(11):634-9. PubMed ID: 2265514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftriaxone therapy in otolaryngological and pulmonary infections.
    Fraschini F; Braga PC; Falchi M; Gattei G; Scaglione F; Scarpazza G; Esposti D
    Chemotherapy; 1986; 32(3):200-4. PubMed ID: 3709268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized study of ciprofloxacin versus ceftriaxone in the treatment of nursing home-acquired lower respiratory tract infections.
    Hirata-Dulas CA; Stein DJ; Guay DR; Gruninger RP; Peterson PK
    J Am Geriatr Soc; 1991 Oct; 39(10):979-85. PubMed ID: 1918785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outpatient treatment of serious community-acquired pediatric infections using once daily intramuscular ceftriaxone.
    Dagan R; Phillip M; Watemberg NM; Kassis I
    Pediatr Infect Dis J; 1987 Dec; 6(12):1080-4. PubMed ID: 3324038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftriaxone. A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration.
    Brogden RN; Ward A
    Drugs; 1988 Jun; 35(6):604-45. PubMed ID: 3048974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftriaxone: an update of its use in the management of community-acquired and nosocomial infections.
    Lamb HM; Ormrod D; Scott LJ; Figgitt DP
    Drugs; 2002; 62(7):1041-89. PubMed ID: 11985490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ceftriaxone in the therapy of infections of the lower respiratory tract: comparison with cefotaxime].
    Lanni N; Scaglione B
    Minerva Med; 1986 Mar; 77(9-10):317-9. PubMed ID: 3485265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of intramuscular cefoperazone versus intramuscular ceftriaxone in patients with nursing home-acquired pneumonia.
    Phillips SL; Branaman-Phillips J
    J Am Geriatr Soc; 1993 Oct; 41(10):1071-4. PubMed ID: 8409152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International experiences with ceftriaxone in the treatment of lower respiratory tract infections.
    Grassi C; Mangiarotti P
    Chemioterapia; 1987 Oct; 6(5):364-73. PubMed ID: 3322589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levofloxacin Versus Ceftriaxone and Azithromycin Combination in the Treatment of Community Acquired Pneumonia in Hospitalized Patients.
    Izadi M; Dadsetan B; Najafi Z; Jafari S; Mazaheri E; Dadras O; Heidari H; SeyedAlinaghi S; Voltarelli F
    Recent Pat Antiinfect Drug Discov; 2018; 13(3):228-239. PubMed ID: 30360748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftriaxone therapy in adults with severe lower respiratory tract infections.
    Potgieter PD; Linton DM; Forder AA; Plumb H
    S Afr Med J; 1986 Apr; 69(8):495-7. PubMed ID: 3961646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of long half-life parenteral cephalosporins in ambulatory practice.
    Sauerwein M; Deamer RL; Prichard JG
    J Fam Pract; 1987 Jan; 24(1):47-51. PubMed ID: 3794613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative clinical evaluation of ceftriaxone in treating lower respiratory tract infections.
    Abbate GF; Alagia I; Giaquinto E; Leonessa V; Caputi M; Guarino C; Micillo E; Catena E; Altucci P
    Chemioterapia; 1986 Feb; 5(1):26-32. PubMed ID: 3955779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefpodoxime proxetil. An appraisal of its use in antibacterial cost-containment programmes, as stepdown and abbreviated therapy in respiratory tract infections.
    Balfour JA; Benfield P
    Pharmacoeconomics; 1996 Aug; 10(2):164-78. PubMed ID: 10163419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of once-daily cephalosporin regimens for community-acquired lower respiratory tract infections in patients with chronic lung disease.
    McCabe RE; Schlossberg D; Donowitz GR; Scheld WM; Zellner SR; Lindenberg LB; Armstrong JH; Ein ME
    Clin Ther; 1989; 11(3):304-14. PubMed ID: 2663160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceftriaxone: a third-generation cephalosporin.
    Nahata MC; Barson WJ
    Drug Intell Clin Pharm; 1985 Dec; 19(12):900-6. PubMed ID: 3910386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levofloxacin: a review of its use in the treatment of bacterial infections in the United States.
    Croom KF; Goa KL
    Drugs; 2003; 63(24):2769-802. PubMed ID: 14664657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftriaxone compared with cefotaxime for serious bacterial infections.
    Smith CR; Petty BG; Hendrix CW; Kernan WN; Garver PL; Fox K; Beamer A; Carbone K; Threlkeld M; Lietman PS
    J Infect Dis; 1989 Sep; 160(3):442-7. PubMed ID: 2668428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.